People In Brief: Bayer, NPA, FTC
This article was originally published in The Tan Sheet
Executive Summary
Dekkers gives Bayer two more years; Hilmas joins NPA; Hobbs directs Rainbow Light science; McSweeney starts at FTC; Bayer’s Mann takes WMSI chair; Archambault leads Ropack development.
You may also be interested in...
FDA Dietary Supplement Programs Research, Strategy Official Moves To NPA
Sibyl Swift is responsible for developing and implementing NPA's educational, regulatory and compliance programs such as SSCI and the NPA Natural Standard. She also will assist members with claim reviews, substantiation and NDI notification policy.
NPA Dusts Off DSHEA Coalition To Expand Industry’s Political Clout
NPA is restarting the Coalition to Preserve DSHEA on its own and other supplement industry trade groups are welcome to join. “We’re going to pick up the pace and really work to gain access the way other FDA-regulated industries do,” says NPA President Daniel Fabricant.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.